Tate & Lyle Ventures

Result of General Meeting

30 September 2021
| Filed in: Press Releases
Image
Yoghurt dessert
On 12 July 2021, Tate & Lyle announced that it had entered into an agreement to sell a controlling stake in a new company and its subsidiaries which will hold Tate & Lyle’s Primary Products business in North America and Latin America and its interests in the Almidones Mexicanos S.A de C.V and DuPont...

Over 273,000 ways we helped in 2018

24 January 2019
| Filed in:
Company Stories
Image
Tate & Lyle community initiatives
Celebrating the start of 2019 with a look back and a look ahead... At Tate & Lyle, we have a deep history of supporting the communities we call home, through sharing our time, talent and resources. In 2018 we made a real impact. We’re proud that we were able to live our purpose of Improving Lives...

Tate & Lyle and Sweet Green Fields to unveil latest stevia innovation at Health Ingredients Europe 2018

19 November 2018
| Filed in: Press Releases
Image
lychee drink
Partnership continues to meet demand for constant innovation in sugar reduction with two new products.

Tate & Lyle names Quadra its Canadian distributor for food and beverage solutions

16 October 2018
| Filed in: Press Releases
Image
Shopper browsing
OCTOBER 2018 – Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, and Quadra, North America’s premier distributor of specialty ingredients and raw materials, today announced an expanded partnership. Tate & Lyle has selected Quadra as its...

Tate & Lyle Ventures delivers latest exit from Fund I

15 September 2015
| Filed in: Press Releases
Image
99 0
London, 15 September 2015 – Tate & Lyle Ventures announced today that its Fund I portfolio company Lumora Ltd has been sold to ERBA Diagnostics Mannheim GmbH (ERBA), a global in vitro diagnostics company.

Tate & Lyle Ventures backs Evolve BioSystems Inc.

18 August 2015
| Filed in: Press Releases
Image
shutterstock 291453335
London, August 18 2015 – Tate & Lyle Ventures announces a $2 million investment in Evolve BioSystems, Inc. a microbiome spin-out company from the University of California at Davis.

Tate & Lyle to expand its global innovation programme through a new £30 million venture fund (Tate & Lyle Ventures II)

08 November 2012
| Filed in: Press Releases
Image
shutterstock 547750876 0
Tate & Lyle PLC announced today an investment of up to £30 million over an eight-year period in a new venture capital fund, building on Tate & Lyle’s existing venture fund activities. The new Fund will invest in start-ups and expansion-stage companies in both developed and emerging markets in food...